The United States is the single largest destination for Indian pharmaceutical products — $15.1B in the most recent year. That figure has grown 3.0× over the past decade, driven by demand for affordable generics and active pharmaceutical ingredients. The vast majority are finished medicines — drug formulations ready for dispensing.
$15.1B
Scale
India supplies $15.1B in pharmaceutical products to United States each year — one of the largest pharmaceutical trade flows in the world.
91%
Medicine
Overwhelmingly finished medicines — drug formulations account for 91% of shipments.
3.0×
Trajectory
Rapid expansion: United States' imports of Indian pharmaceutical products have grown 3.0× over the past decade, from $4.8B to $15.1B.
#1
Context
India's largest pharmaceutical export destination.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in United States — building trade and operational presence.
India also supplied $518M in active pharmaceutical ingredients
and bulk drugs to United States in 2025 (India-reported, DGCIS).
The relationship flows both ways. American pharmaceutical companies are among the largest investors in India's health ecosystem — operating manufacturing plants, R&D centres, and clinical trial networks across the country.
Johnson & Johnson
$94B global revenue
138,200 employees
DARZALEX (Oncology) · STELARA (Immunology) · TREMFYA (Immunology)
Pfizer
$64B global revenue
81,000 employees
Eliquis (Cardiovascular) · Prevnar (Vaccines) · Paxlovid (Anti-infectives)
AbbVie
$61B global revenue
57,000 employees
Skyrizi (Immunology) · Rinvoq (Immunology) · Humira (Immunology)
MSD (Merck & Co)
$60B global revenue
72,000 employees
KEYTRUDA (Oncology) · GARDASIL (Vaccines) · JANUVIA (Diabetes)
Bristol Myers Squibb
$48B global revenue
30,000 employees
Eliquis (Cardiovascular) · Opdivo (Oncology) · Revlimid (Hematology)
Eli Lilly
$45B global revenue
47,000 employees
Mounjaro (Diabetes) · Verzenio (Oncology) · Zepbound (Obesity)